M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen Mikio IgawaHitoshi KadenaTsuguru Usui Session 1: Advance Bladder Cancer Pages: S1 - S4
The effect of dose intensity on M-VAC therapy for advanced urothelial cancer Naoto MiyanagaHideyuki AkazaKenkichi Koiso Session 1: Advance Bladder Cancer Pages: S5 - S8
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer Masao KurodaNorio MeguroToshihiko Kotake Session 1: Advance Bladder Cancer Pages: S9 - S13
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis Hiroaki KobayashiKoji Obata Session 1: Advance Bladder Cancer Pages: S14 - S17
Chemotherapy for endocrine-therapy-refractory prostate cancer Susumu AkimotoTakemasa OhkiJun Shimazaki Session 2: Prostate Cancer Pages: S18 - S22
Chemo-endocrine therapy for prostate cancer with bone metastasis Hideki SakaiYuzo MinamiNagasaki Prostate Cancer Research Group Session 2: Prostate Cancer Pages: S23 - S26
Intra-arterial chemotherapy using a reservoir for endocrine-refractory prostate cancer Manabu KuriyamaToshimi TakeuchiYukimichi Kawada Session 2: Prostate Cancer Pages: S27 - S30
A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer Kikuo OkamuraTatsuro MuraseThe Nagoya University Urological Oncology Group Session 3: Superficial Bladder Cancer Pages: S31 - S35
Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory Yoshihiko HiraoSeiichiro OzonoMembers of Nara Uro-oncology Research Group (NUORG) Session 3: Superficial Bladder Cancer Pages: S36 - S40
Prophylactic chemotherapy with anthracyclines (Adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer Nobuo ShinoharaKatsuya NonomuraThe Hokkaido University Bladder Cancer Collaborative Group Session 3: Superficial Bladder Cancer Pages: S41 - S45
Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial Hiroshi EtoYasuhiko OkaKobe University Urological Oncology Group Session 3: Superficial Bladder Cancer Pages: S46 - S51
A phase II study of prophylactic intravesical chemotherapy with 4′-epirubicin in recurrent superficial bladder cancer: comparison of 4′-epirubicin and Adriamycin Taro ShuinYoshinobu KubotaHiroshi Fukuoka Session 3: Superficial Bladder Cancer Pages: S52 - S56
Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors Nobuyuki WatanabeIkuo MiyagawaTottori University Oncology Group Session 3: Superficial Bladder Cancer Pages: S57 - S59
A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer Osamu RyojiHiroshi TomaTokyo Women's Medical College Bladder Cancer Collaborating Group Session 3: Superficial Bladder Cancer Pages: S60 - S64
The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report Yasunari UekadoAtsuyuki HiranoTadashi Ohkawa Session 3: Superficial Bladder Cancer Pages: S65 - S68
Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial Tomoyasu TsushimaHiroyuki OhmoriYasuo Ohashi Session 3: Superficial Bladder Cancer Pages: S69 - S75
Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results Seiji NaitoToyofumi UedaThe Kyushu University Urological Oncology Group Session 3: Superficial Bladder Cancer Pages: S76 - S80
Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma Kousuke UedaHiroshi SakagamiTakehiko Okamura Session 3: Superficial Bladder Cancer Pages: S81 - S83
Studies of effects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique Tadao UchibayashiSoo-Woong LeeTakuma Sasaki Session 3: Superficial Bladder Cancer Pages: S84 - S87
Prophylactic chemotherapy with intravesical instillation of Adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer Koji ObataYasuo OhashiThe Japanese Urological Cancer Research Group for Adriamycin Session 3: Superficial Bladder Cancer Pages: S88 - S92
Advanced bladder cancer: options of therapy J. Edson Pontes Session 4: State of the Art in Urinary Tract Tumors Pages: S93 - S96
Experiences with doxo/epirubicin and medroxyprogesterone acetate (MPA) in prostatic cancer Claes Anderström Session 4: State of the Art in Urinary Tract Tumors Pages: S97 - S100
Superficial bladder cancer: state of the art A. V. Bono Session 4: State of the Art in Urinary Tract Tumors Pages: S101 - S109